诺瓦瓦克斯Q2业绩超预期 上调全年调整后营收指引

格隆汇
Aug 06, 2025

疫苗生产商诺瓦瓦克斯公布第二季度业绩,营收为2.39亿美元,高于分析师预期的1.4796亿美元;每股收益0.62美元,亦超预期。公司称,因COVID-19疫苗在美国获批,获得了1.75亿美元的里程碑付款。公司目前预计全年调整后营收将在10亿至10.5亿美元之间,而之前预期为9.75亿至10.3亿美元,分析师预期为10.3亿美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10